tradingkey.logo

OraSure Technologies Inc

OSUR
2.400USD
-0.170-6.61%
Cierre 11/06, 16:00ETCotizaciones retrasadas 15 min
173.44MCap. mercado
PérdidaP/E TTM

OraSure Technologies Inc

2.400
-0.170-6.61%

Más Datos de OraSure Technologies Inc Compañía

OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Información de OraSure Technologies Inc

Símbolo de cotizaciónOSUR
Nombre de la empresaOraSure Technologies Inc
Fecha de salida a bolsaNov 17, 1986
Director ejecutivoMs. Carrie Eglinton Manner
Número de empleados501
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 17
Dirección220 E First St
CiudadBETHLEHEM
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal18015
Teléfono15036416115
Sitio Webhttps://www.orasure.com/
Símbolo de cotizaciónOSUR
Fecha de salida a bolsaNov 17, 1986
Director ejecutivoMs. Carrie Eglinton Manner

Ejecutivos de OraSure Technologies Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kenneth J. (Ken) Mcgrath
Mr. Kenneth J. (Ken) Mcgrath
Chief Financial Officer
Chief Financial Officer
448.46K
-2.72%
Dr. Nancy J. Gagliano, M.D.
Dr. Nancy J. Gagliano, M.D.
Independent Director
Independent Director
158.15K
+72.80%
Mr. John P. Kenny
Mr. John P. Kenny
Independent Chairman of the Board
Independent Chairman of the Board
153.32K
+4.16%
Mr. Lelio Marmora
Mr. Lelio Marmora
Independent Director
Independent Director
130.76K
+93.09%
Hon Dr. David J. Shulkin, M.D.
Hon Dr. David J. Shulkin, M.D.
Independent Director
Independent Director
126.33K
+109.45%
Ms. Anne Messing
Ms. Anne Messing
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Steven Boyd ,
Mr. Steven Boyd ,
Independent Director
Independent Director
--
--
Mr. Robert W. Mcmahon
Mr. Robert W. Mcmahon
Independent Director
Independent Director
--
--
Mr. Jason Plagman
Mr. Jason Plagman
Vice President - Investor Relations
Vice President - Investor Relations
--
--
Ms. Carrie Eglinton Manner
Ms. Carrie Eglinton Manner
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kenneth J. (Ken) Mcgrath
Mr. Kenneth J. (Ken) Mcgrath
Chief Financial Officer
Chief Financial Officer
448.46K
-2.72%
Dr. Nancy J. Gagliano, M.D.
Dr. Nancy J. Gagliano, M.D.
Independent Director
Independent Director
158.15K
+72.80%
Mr. John P. Kenny
Mr. John P. Kenny
Independent Chairman of the Board
Independent Chairman of the Board
153.32K
+4.16%
Mr. Lelio Marmora
Mr. Lelio Marmora
Independent Director
Independent Director
130.76K
+93.09%
Hon Dr. David J. Shulkin, M.D.
Hon Dr. David J. Shulkin, M.D.
Independent Director
Independent Director
126.33K
+109.45%
Ms. Anne Messing
Ms. Anne Messing
Chief Commercial Officer
Chief Commercial Officer
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Net product and services revenues - COVID-19
14.40M
46.09%
Net product and services revenues - HIV
9.86M
31.54%
Net product and service revenues -Molecular Products
4.13M
13.21%
Other revenues - Other non Product revenues
1.40M
4.47%
Net product and services revenues - Risk assessment testing
994.00K
3.18%
Otro
474.00K
1.52%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
19.85M
63.54%
Africa (Region)
8.03M
25.69%
Europe
2.12M
6.78%
Other Regions
1.25M
3.99%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Net product and services revenues - COVID-19
14.40M
46.09%
Net product and services revenues - HIV
9.86M
31.54%
Net product and service revenues -Molecular Products
4.13M
13.21%
Other revenues - Other non Product revenues
1.40M
4.47%
Net product and services revenues - Risk assessment testing
994.00K
3.18%
Otro
474.00K
1.52%

Estadísticas de accionistas

Actualizado: mar., 19 de ago
Actualizado: mar., 19 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Private Management Group, Inc.
7.61%
BlackRock Institutional Trust Company, N.A.
7.58%
The Vanguard Group, Inc.
5.81%
Neuberger Berman, LLC
5.79%
Altai Capital Management, L.P.
5.23%
Otro
67.98%
Accionistas
Accionistas
Proporción
Private Management Group, Inc.
7.61%
BlackRock Institutional Trust Company, N.A.
7.58%
The Vanguard Group, Inc.
5.81%
Neuberger Berman, LLC
5.79%
Altai Capital Management, L.P.
5.23%
Otro
67.98%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
40.12%
Investment Advisor/Hedge Fund
27.45%
Hedge Fund
21.36%
Individual Investor
5.12%
Research Firm
2.35%
Pension Fund
0.44%
Bank and Trust
0.30%
Venture Capital
0.09%
Insurance Company
0.04%
Otro
2.73%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
451
67.31M
92.04%
-15.49M
2025Q2
473
72.08M
98.55%
-16.70M
2025Q1
483
70.23M
93.78%
-12.52M
2024Q4
475
70.81M
94.94%
-10.37M
2024Q3
471
70.30M
94.28%
-10.80M
2024Q2
477
73.05M
98.74%
-8.54M
2024Q1
473
74.45M
97.36%
-5.59M
2023Q4
464
73.29M
99.74%
-5.62M
2023Q3
456
72.50M
98.73%
-4.51M
2023Q2
452
70.73M
96.51%
-2.77M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Private Management Group, Inc.
5.46M
7.47%
+1.04M
+23.64%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.43M
7.43%
-141.00K
-2.53%
Jun 30, 2025
The Vanguard Group, Inc.
4.17M
5.7%
-120.08K
-2.80%
Jun 30, 2025
Neuberger Berman, LLC
4.16M
5.68%
-124.14K
-2.90%
Jun 30, 2025
Altai Capital Management, L.P.
3.75M
5.13%
+1.59M
+73.37%
Sep 02, 2025
Dimensional Fund Advisors, L.P.
3.84M
5.25%
+14.96K
+0.39%
Jun 30, 2025
Renaissance Technologies LLC
2.28M
3.11%
-294.84K
-11.47%
Jun 30, 2025
Systematic Financial Management, L.P.
2.23M
3.05%
+581.93K
+35.33%
Jun 30, 2025
Acadian Asset Management LLC
2.19M
3%
-563.24K
-20.44%
Jun 30, 2025
American Century Investment Management, Inc.
2.08M
2.85%
-423.60K
-16.91%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: hace 22 horas
Actualizado: hace 22 horas
Nombre
Proporción
Invesco NASDAQ Future Gen 200 ETF
0.47%
iShares US Small Cap Value Factor ETF
0.38%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.07%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
Avantis US Small Cap Equity ETF
0.03%
WisdomTree US SmallCap Fund
0.03%
iShares US Small-Cap Equity Factor ETF
0.02%
iShares Russell 2000 Value ETF
0.02%
ProShares UltraPro Russell2000
0.01%
Ver más
Invesco NASDAQ Future Gen 200 ETF
Proporción0.47%
iShares US Small Cap Value Factor ETF
Proporción0.38%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporción0.07%
iShares Micro-Cap ETF
Proporción0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.05%
Avantis US Small Cap Equity ETF
Proporción0.03%
WisdomTree US SmallCap Fund
Proporción0.03%
iShares US Small-Cap Equity Factor ETF
Proporción0.02%
iShares Russell 2000 Value ETF
Proporción0.02%
ProShares UltraPro Russell2000
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI